Abstract
Allergic Conjunctivitis (AC) affects 15-20% of the worldwide population. Environmental exposure chamber (EEC) may facilitate clinical trials as it mimics natural allergen exposure, in a controlled setting which may aid in the selection of adequately allergic AC subjects.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
